Point72 Asset Management
RCUS icon

Point72 Asset Management’s Arcus Biosciences RCUS Stock Holding History

Point72 Asset Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.79M Sell
129,273
-3,150,727
-96% -$68M ﹤0.01% 2099
2025
Q4 		$78.2M Sell
3,280,000
-1,052,479
-24% -$21.5M 0.09% 250
2025
Q3 		$58.9M Sell
4,332,479
-1,634,185
-27% -$17M 0.1% 229
2025
Q2 		$48.6M Buy
5,966,664
+3,099,567
+108% +$26.5M 0.1% 257
2025
Q1 		$22.5M Buy
2,867,097
+870,818
+44% +$10.1M 0.05% 421
2024
Q4 		$29.7M Sell
1,996,279
-440,794
-18% -$7.2M 0.07% 341
2024
Q3 		$37.3M Buy
2,437,073
+603,222
+33% +$9.51M 0.09% 251
2024
Q2 		$27.9M Sell
1,833,851
-81,081
-4% -$1.31M 0.07% 323
2024
Q1 		$36.2M Buy
1,914,932
+1,146,182
+149% +$19.8M 0.09% 279
2023
Q4 		$14.7M Buy
768,750
+764,293
+17,148% +$12.2M 0.04% 549
2023
Q3 		$80K Sell
4,457
-705,184
-99% -$14.2M ﹤0.01% 2027
2023
Q2 		$14.4M Buy
+709,641
New +$13.5M 0.04% 481
2023
Q1 		– Sell
-425,301
Closed -$8.8M – 2494
2022
Q4 		$8.8M Buy
425,301
+367,467
+635% +$10.1M 0.03% 594
2022
Q3 		$1.51M Buy
+57,834
New +$1.53M 0.01% 988
2021
Q2 		– Sell
-62,926
Closed -$1.77M – 1136
2021
Q1 		$1.77M Buy
+62,926
New +$2.19M 0.01% 744
2020
Q4 		– Sell
-194,001
Closed -$3.33M – 1097
2020
Q3 		$3.33M Buy
+194,001
New +$4.33M 0.02% 635

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Point72 Asset Management's RCUS Position: Q1 2026 in Review

Point72 Asset Management reduced its Arcus Biosciences (RCUS) stake by 96% in Q1 2026, selling an estimated $68M and leaving 129,273 shares worth $2.79M. The position accounts for ﹤0.01% of the portfolio, ranked #2099.

Point72 Asset Management first reported a position in RCUS in Q3 2020 and has held it in 16 quarters since. The position peaked at $78.2M in Q4 2025. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • Point72 Asset Management held 129,273 shares of Arcus Biosciences worth $2.79M as of Q1 2026.
  • Point72 Asset Management sold 3,150,727 Arcus Biosciences shares in Q1 2026, an estimated $68M.
  • Arcus Biosciences made up ﹤0.01% of Point72 Asset Management's portfolio in Q1 2026, its #2099 holding.
  • Point72 Asset Management first reported a position in Arcus Biosciences in Q3 2020 and has held it in 16 quarters since.
  • Point72 Asset Management's Arcus Biosciences position peaked at $78.2M in Q4 2025.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.